RT Journal Article
SR Electronic
T1 Determinants of Eye Care Service Utilization Among Malawian adults; A Secondary Analysis of the Malawi fifth Integrated Household Survey 2019-2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.09.22282125
DO 10.1101/2022.11.09.22282125
A1 Mzumara, Thokozani
YR 2022
UL http://medrxiv.org/content/early/2022/11/15/2022.11.09.22282125.abstract
AB Purpose The aim of the study was to assess the self-reported Eye Care Utilization (ECU) and associated demographic factors among Malawians adults.Methods This study utilized secondary data from the Malawi Integrated Health Survey (IHS) 5 2019-2020. We entered age, sex, level of education, residency(urban/rural) and having chronic disease into a logistic regression model and used a confusion matrix to predict the accuracy of the model.Results The prevalence of ECU was 60.6% (95% CI [60.0,61.2]). The model was statistically significant and correctly classified 72 % of the cases. A logistic regression showed that ECU was positively associated with education compared to none (OR=3.6, 95 % CI [3.104-4.097], p&lt;0.001, (OR =6.6), CI [5.927,7.366], p&lt;0.001), male gender compared to females (OR= 1.2, 95% CI [1.104,1.290], p&lt;0.001), urban residence compared to rural areas (OR= 1.2, 95% CI [1.118,1.375], p&lt;0.001). But It was negatively associated with age compared to young adults, middle age (OR =7.5, 95% CI [6.782,8.476], p&lt;0.001), older age (OR=0.9, 95 % CI [0.866,1.035], p&lt;0.001), and having chronic diseases (OR=0.6, 95 % CI= [0.547,0.708], p&lt;0.001).Conclusion Social support, women empowerment, education, and mobile clinics are key strategic areas that would increase Access to eye care in Malawi. Further studies can investigate ECU among the pediatric population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:we obtained permission to access publically available datasetsI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://microdata.worldbank.org/index.php/catalog/2939.https://microdata.worldbank.org/index.php/catalog/2939.